GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biotoxtech Co Ltd (XKRX:086040) » Definitions » Deferred Tax

Biotoxtech Co (XKRX:086040) Deferred Tax : ₩3,481 Mil (TTM As of Mar. 2025)


View and export this data going back to 2007. Start your Free Trial

What is Biotoxtech Co Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Biotoxtech Co's change in deferred tax for the three months ended in Mar. 2025 was ₩-322 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Mar. 2025 was ₩3,481 Mil.

Biotoxtech Co Deferred Tax Historical Data

The historical data trend for Biotoxtech Co's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotoxtech Co Deferred Tax Chart

Biotoxtech Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Deferred Tax
Get a 7-Day Free Trial Premium Member Only Premium Member Only 878.51 -209.47 -277.32 -2,882.86 3,835.52

Biotoxtech Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.45 -106.81 97.00 3,812.88 -322.28

Biotoxtech Co Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩3,481 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biotoxtech Co Deferred Tax Related Terms

Thank you for viewing the detailed overview of Biotoxtech Co's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotoxtech Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biotoxtech Co Ltd (XKRX:086040) » Definitions » Deferred Tax
Comparable Companies
XKRX:303360 XKRX:221800 XKRX:246250 XKRX:109820 XKRX:363250 XKRX:229000 XKRX:950200 XKRX:031860 XKRX:122310 XKRX:153710 TMO DHR XSWX:LONN IDXX A SHSE:603259 IQV MTD NTRA WAT
Traded in Other Exchanges
N/A
Address
686-2 Yangcheong-Ri, Ochang-Eup, Cheongwon-Gun, Chungbuk, KOR, 353-883
Website
http://www.biotoxtech.com
Biotoxtech Co Ltd assesses safety for medical products, cosmetics, food, and chemical material. It also conducts validity tests and material screening and provides consulting services for non-clinical tests.

Biotoxtech Co Headlines

No Headlines